Skip to main content
. 2016 May 31;139(6):1391–1401. doi: 10.1002/ijc.30182

Figure 4.

Figure 4

Persistent production of WT1‐235 IgG antibody during long‐term WT1 vaccination. Serum WT1‐235 IgG antibody was measured at the indicated time points in two GBM patients in whom tumor was controlled for more than 1 year. Intervals of WT1 peptide vaccination were 1 week in 3 months after the start of WT1 peptide vaccination, which was then gradually extended to 2, 3, and 4 weeks.